Eventually, I got everything together, played through Alyx, and had a great time. But, as rumors swirl that the announcement ...

Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) has been given a consensus recommendation of “Buy” by the seven analysts that are presently covering the firm, Marketbeat Ratings reports.

Fluoride exposure appears to slightly decrease IQ scores in children, a new federal meta-analysis has concluded -- but not at ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

MBX Biosciences Inc. (NASDAQ:MBX) revealed results from its Phase 1 single ascending dose and multiple ascending dose trial ...

Combining Adderall with other CNS stimulants, such as caffeine, can increase the risk of side effects, including elevated ...

After a great 2024, the survival genre boom is only gonna get bigger.

Months after posting weight loss of 7.5% at 36 days for patients taking MET-097i, Metsera releases mid-stage results of just ...

A compound derived from Nectandra leucantha, a tree native to southern Brazil (local names: canela-seca or canela-branca), ...

MBX Biosciences (MBX) announced positive results from its Phase 1 single ascending dose, SAD, and multiple ascending dose, MAD, clinical trial ...

Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH), which is expected to begin ...